Technology Trends in Drug Discovery and Development: Implications for the Development of the Pharmaceutical Industry in Australia
暂无分享,去创建一个
[1] J. DiMasi,et al. New Drug Innovation and Pharmaceutical Industry Structure: Trends in the Output of Pharmaceutical Firms , 2000 .
[2] L Lasagna,et al. Cost of innovation in the pharmaceutical industry. , 1991, Journal of health economics.
[3] I. Cockburn,et al. Scale and scope in drug development: unpacking the advantages of size in pharmaceutical research. , 2001, Journal of health economics.
[4] Samuel B. Graves,et al. Innovative output and firm size in the pharmaceutical industry , 1992 .
[5] Ronald J. Quinn,et al. High‐throughput screening in natural product drug discovery in Australia utilising Australia's biodiversity , 1999 .
[6] Ajay K. Royyuru,et al. Blue Gene: A vision for protein science using a petaflop supercomputer , 2001, IBM Syst. J..
[7] A. Berger,et al. A revolution in drug discovery , 2000, BMJ : British Medical Journal.
[8] Henry G. Grabowski,et al. R&d Costs, Innovative Output and Firm Size in the Pharmaceutical Industry , 1995 .
[9] Jürgen Drews,et al. Innovation Deficit in the Pharmaceutical Industry , 1996 .
[10] Jean-Charles Sanchez,et al. Proteomics: new perspectives, new biomedical opportunities , 2000, The Lancet.
[11] P M Dean,et al. Industrial-scale, genomics-based drug design and discovery. , 2001, Trends in biotechnology.
[12] C. Ezzell. Magic bullets fly again. , 2001, Scientific American.
[13] Lahana,et al. How many leads from HTS? , 1999, Drug discovery today.
[14] John Houghton,et al. Information Technology and the Revolution in Healthcare , 2002 .
[15] K. James,et al. The Impact of Technological Advances on Drug Discovery Today , 2001 .
[16] D. Bailey,et al. High-throughput chemistry and structure-based design: survival of the smartest. , 2001, Drug discovery today.